Literature DB >> 25038873

Time- and frequency-domain parameters of heart rate variability and sympathetic skin response in Parkinson's disease.

Walter Maetzler1, Marie Karam, Monika Fruhmann Berger, Tanja Heger, Corina Maetzler, Heinz Ruediger, Juliana Bronzova, Patricia Pita Lobo, Joaquim J Ferreira, Tjalf Ziemssen, Daniela Berg.   

Abstract

The autonomic nervous system (ANS) is regularly affected in Parkinson's disease (PD). Information on autonomic dysfunction can be derived from e.g. altered heart rate variability (HRV) and sympathetic skin response (SSR). Such parameters can be quantified easily and measured repeatedly which might be helpful for evaluating disease progression and therapeutic outcome. In this 2-center study, HRV and SSR of 45 PD patients and 26 controls were recorded. HRV was measured during supine metronomic breathing and analyzed in time- and frequency-domains. SSR was evoked by repetitive auditory stimulation. Various ANS parameters were compared (1) between patients and healthy controls, (2) to clinical scales (Unified Parkinson's disease rating scale, Mini-Mental State Examination, Becks Depression Inventory), and (3) to disease duration. Root mean square of successive differences (RMSSD) and low frequency/high frequency (LF/HF) ratio differed significantly between PD and controls. Both, HRV and SSR parameters showed low or no association with clinical scores. Time-domain parameters tended to be affected already at early PD stages but did not consistently change with longer disease duration. In contrast, frequency-domain parameters were not altered in early PD phases but tended to be lower (LF, LF/HF ratio), respectively higher (HF) with increasing disease duration. This report confirms previous results of altered ANS parameters in PD. In addition, it suggests that (1) these ANS parameters are not relevantly associated with motor, behavioral, and cognitive changes in PD, (2) time-domain parameters are useful for the assessment of early PD, and (3) frequency-domain parameters are more closely associated with disease duration.

Entities:  

Mesh:

Year:  2014        PMID: 25038873     DOI: 10.1007/s00702-014-1276-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  33 in total

1.  Heart rate variability in patients with untreated Parkinson's disease.

Authors:  M Kallio; T Haapaniemi; J Turkka; K Suominen; U Tolonen; K Sotaniemi; V P Heikkilä; V Myllylä
Journal:  Eur J Neurol       Date:  2000-11       Impact factor: 6.089

2.  The trigonometric regressive spectral analysis--a method for mapping of beat-to-beat recorded cardiovascular parameters on to frequency domain in comparison with Fourier transformation.

Authors:  H Rüdiger; L Klinghammer; K Scheuch
Journal:  Comput Methods Programs Biomed       Date:  1999-01       Impact factor: 5.428

3.  Reduced sympathetically driven heart rate variability during sleep in Parkinson's disease: a case-control polysomnography-based study.

Authors:  Nicolas Sauvageot; Michel Vaillant; Nico J Diederich
Journal:  Mov Disord       Date:  2011-01-31       Impact factor: 10.338

4.  Autonomic dysfunction in Parkinson's disease assessed by sympathetic skin response: a prospective clinical and neurophysiological trial on 50 patients.

Authors:  H J Braune; A M Korchounov; H I Schipper
Journal:  Acta Neurol Scand       Date:  1997-05       Impact factor: 3.209

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.

Authors:  S Orimo; E Ozawa; S Nakade; T Sugimoto; H Mizusawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

7.  Baroreflex sensitivity and power spectral analysis during autonomic testing in different extrapyramidal syndromes.

Authors:  Constanze Friedrich; Heinz Rüdiger; Claudia Schmidt; Birgit Herting; Silke Prieur; Susann Junghanns; Katherine Schweitzer; Christoph Globas; Ludger Schöls; Daniela Berg; Heinz Reichmann; Tjalf Ziemssen
Journal:  Mov Disord       Date:  2010-02-15       Impact factor: 10.338

8.  Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.

Authors:  Manja Reimann; Claudia Schmidt; Birgit Herting; Silke Prieur; Susann Junghanns; Katherine Schweitzer; Christoph Globas; Ludger Schoels; Heinz Reichmann; Daniela Berg; Tjalf Ziemssen
Journal:  J Neural Transm (Vienna)       Date:  2009-09-17       Impact factor: 3.575

9.  α-Synuclein in cutaneous autonomic nerves.

Authors:  Ningshan Wang; Christopher H Gibbons; Jacob Lafo; Roy Freeman
Journal:  Neurology       Date:  2013-10-02       Impact factor: 9.910

Review 10.  Cardiovascular autonomic dysfunction in Parkinson's disease.

Authors:  Tjalf Ziemssen; Heinz Reichmann
Journal:  J Neurol Sci       Date:  2009-09-08       Impact factor: 3.181

View more
  12 in total

1.  Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease.

Authors:  Claudia Carricarte Naranjo; Connie Marras; Naomi P Visanji; David J Cornforth; Lazaro Sanchez-Rodriguez; Birgitt Schüle; Samuel M Goldman; Mario Estévez; Phyllis K Stein; Anthony E Lang; Herbert F Jelinek; Andrés Machado
Journal:  Clin Auton Res       Date:  2019-08-23       Impact factor: 4.435

2.  Heart rate variability and the risk of Parkinson disease: The Atherosclerosis Risk in Communities study.

Authors:  Alvaro Alonso; Xuemei Huang; Thomas H Mosley; Gerardo Heiss; Honglei Chen
Journal:  Ann Neurol       Date:  2015-03-27       Impact factor: 10.422

3.  Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype.

Authors:  Paolo Solla; Christian Cadeddu; Antonino Cannas; Martino Deidda; Nicola Mura; Giuseppe Mercuro; Francesco Marrosu
Journal:  J Neural Transm (Vienna)       Date:  2015-03-24       Impact factor: 3.575

4.  Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.

Authors:  Felix P Bernhard; Sebastian Heinzel; Gerhard Binder; Karin Weber; Anja Apel; Benjamin Roeben; Christian Deuschle; Mirjam Maechtel; Tanja Heger; Susanne Nussbaum; Thomas Gasser; Walter Maetzler; Daniela Berg
Journal:  PLoS One       Date:  2016-03-11       Impact factor: 3.240

Review 5.  Parkinson's disease between internal medicine and neurology.

Authors:  Ilona Csoti; Wolfgang H Jost; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2015-08-23       Impact factor: 3.575

6.  Autonomic and peripheral nervous system function in acute tick-borne encephalitis.

Authors:  Bernhard Neumann; Wilhelm Schulte-Mattler; Sophie Brix; Peter Pöschl; Wolfgang Jilg; Ulrich Bogdahn; Andreas Steinbrecher; Ingo Kleiter
Journal:  Brain Behav       Date:  2016-05-05       Impact factor: 2.708

7.  Autonomic Dysfunction in Wilson's Disease: A Comprehensive Evaluation during a 3-Year Follow Up.

Authors:  Kai Li; Charlotte Lindauer; Rocco Haase; Heinz Rüdiger; Heinz Reichmann; Ulrike Reuner; Tjalf Ziemssen
Journal:  Front Physiol       Date:  2017-10-10       Impact factor: 4.566

8.  Sympathetic skin response and heart rate variability in predicting autonomic disorders in patients with Parkinson disease.

Authors:  Jiang-Qiong Ke; Sheng-Min Shao; Yuan-Yuan Zheng; Fang-Wang Fu; Guo-Qing Zheng; Chun-Feng Liu
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

9.  Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson's disease.

Authors:  Kinan Muhammed; Sanjay Manohar; Michael Ben Yehuda; Trevor T-J Chong; George Tofaris; Graham Lennox; Marko Bogdanovic; Michele Hu; Masud Husain
Journal:  Brain       Date:  2016-07-24       Impact factor: 13.501

10.  Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson's disease.

Authors:  Kai Li; Rocco Haase; Heinz Rüdiger; Manja Reimann; Heinz Reichmann; Martin Wolz; Tjalf Ziemssen
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.